CAO, Y.; SHI, . F. .; LI, Y. .; WEI, X. .; YI, . H. .; HAN, S. . Cost-effectiveness analysis of the combination of low-dose nivolumab with triple metronomic chemotherapy for advanced head and neck squamous cell carcinoma in China. Health Decision, [S. l.], v. 2, n. S1, 2024. DOI: 10.54844/hd.2024.0008. Disponível em: https://www.hksmp.com/journals/hd/article/view/654. Acesso em: 2 may. 2025.